Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-26T13:17:30.909Z Has data issue: false hasContentIssue false
  • English
  • Français

Serum phospholipid fatty acid pattern is associated with bone mineral density in children, but not adults, with cystic fibrosis

Published online by Cambridge University Press:  08 March 2007

Eva Gronowitz ,
D Mellström  and
B Strandvik
Eva Gronowitz
Affiliation:
Department of PaediatricsSahlgrenska AcademyGothenburg UniversityQueen Silvia Children's HospitalSE-41685 GothenburgSweden
D Mellström
Affiliation:
Department of GeriatricsSahlgrenska AcademyGothenburg UniversityQueen Silvia Children's HospitalSE-41685 GothenburgSweden
B Strandvik*
Affiliation:
Department of PaediatricsSahlgrenska AcademyGothenburg UniversityQueen Silvia Children's HospitalSE-41685 GothenburgSweden
*
*Corresponding author: Dr Birgitta Strandvik, fax +46 31 217023, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Essential fatty acids (EFA) have proved to be important for normal bone mineral density (BMD) and bone growth in animal studies. Patients with cystic fibrosis often have low serum EFA levels, and low BMD has also been reported in patients with normal anthropometry. The aim of the present study was to analyse if BMD during a 2-year period was related to fatty acid status in patients with cystic fibrosis. Fifty-four patients, aged 6–33 years, were studied prospectively. BMD was measured with dual X-ray absorptiometry, and fatty acid concentrations in serum phospholipids were determined with capillary GLC. The cystic fibrosis patients showed low linoleic acid concentration and a high arachidonic acid (AA):DHA ratio in serum. The high eicosatrienoic acid:AA ratio, an indicator of EFA deficiency, increased further over 2 years, as did the total concentration of saturated fatty acids. In the adults there were no significant changes in fatty acids during the study. In the children, positive correlations were found between palmitic acid and bone mineral content in the lumbar spine and femoral neck. The lumbar spine BMD Z score correlated negatively with the AA:DHA ratio. No correlation was seen in adults except for a positive correlation between EFA deficiency index and the areas of lumbar spine and femoral neck. The present results imply that fatty-acid status influenced BMD in cystic fibrosis children, but not in adults, indicating that fatty-acid status wouldbe important for bone growth.

Keywords

Arachidonic acidDocosahexaenoic acidEicosatrienoic acidLinoleic acid
Type
Research Article
Information
British Journal of Nutrition , Volume 95 , Issue 6 , June 2006 , pp. 1159 - 1165
Copyright
Copyright © The Nutrition Society 2006

References

Ahme, ML, Ong, KK & Dunger, DBThomson, AH, Reduced gains in fat and fat-free mass, and elevated leptin levels in children and adolescents with cystic fibrosis. Acta Paediatr 2004 93 1185–1191.CrossRefGoogle ScholarPubMed
Arumugam, R, LeBlanc, A, Seilheimer, DK & Hardin, DSSerum leptin and IGF-I levels in cystic fibrosis. Endocr Res 1998 24 247–257.CrossRefGoogle ScholarPubMed
Bachrach, LK, Hastie, T, Wang, MC, Narasimhan, B & Marcus, RBone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study. J Clin Endocrinol Metab 1999 84 4702–4712.Google ScholarPubMed
Berguerand, M, Klapisz, E, Thomas, G, Humbert, L, Jouniaux, AM, Olivier, JL, Bereziat, G & Masliah, JDifferential stimulation of cytosolic phosphatase A2 by bradykinin in human cystic fibrosis cell lines. Am J Respir Cell Mol Biol 1997 17 481–490.CrossRefGoogle Scholar
Blomquist, M, Freyschuss, U, Wiman, LG & Strandvik, BPhysical activity and self treatment in cystic fibrosis. Arch Dis Child 1986 61 362–367.CrossRefGoogle ScholarPubMed
Buntain, HM, Greer, RM, Schluter, PJ, Wong, JC, Batch, JA, Potter, JM, Lewindon, PJ, Powell, E, Wainwright, CE & Bell, SCBone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax 2004 59 149–155.CrossRefGoogle ScholarPubMed
Carlstedt-Duke, J, Brönnegård, M & Strandvik, B, Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect. Proc Natl Acad Sci USA 1986 83 9202–9206.CrossRefGoogle ScholarPubMed
Conway, SP, Morton, AM, Oldroyd, B, Truscott, JG, White, H, Smith, AH & Haigh, IOsteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 2000 55 798–804.CrossRefGoogle ScholarPubMed
Freedman, SD, Blanco, PG, Zaman, MM,, et al.. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 2004 350 560–569.CrossRefGoogle ScholarPubMed
Freedman, SD, Katz, MH, Parker, EM, Laposata, M, Urman, MY & Alvarez, JGA membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr (-/-) mice. Proc Natl Acad Sci USA. 1999 96 13995–14000.Google Scholar
Garcia, C, Boyce, BF, Gilles, J, Dallas, M, Qiao, M, Mundy, GR & Bonewald, LFLeukotriene B4 stimulates osteoclasstic bone resorption both in vitro and in vivo. J Bone Min Res 1996 11 1619–1627.CrossRefGoogle ScholarPubMed
Gronowitz, E, Garemo, M, Lindblad, A, Mellström, D & Strandvik, BDecreased bone mineral density in normal growing patients with cystic fibrosis. Acta Paediatr 2003 92 688–693.CrossRefGoogle ScholarPubMed
Gronowitz, E, Mellström, D & Strandvik, B, Normal annual increase of bone mineral density during two years in patients with cystic fibrosis. Pediatrics 2004 114 435–442.CrossRefGoogle ScholarPubMed
Gunnes, M & Lehmann, EHDietary calcium, saturated fat, fiber and vitamin C as predictors of forearm cortical and trabecular bone mineral density in healthy children and adolescents. Acta Paediatr 1995 84 388–392.CrossRefGoogle ScholarPubMed
Hardin, DS, Arumugam, R, Seilheimer, DK, LeBlanc, A & Ellis, KJNormal bone mineral density in cystic fibrosis. Arch Dis Child 2001 84 363–368.CrossRefGoogle ScholarPubMed
Haworth, CS, Selby, PL, Webb, AK, et al.. Low bone mineral density in adults with cystic fibrosis. Thorax 1999 54 961–967.CrossRefGoogle ScholarPubMed
Holman, RTEssential fatty acid deficiency. Prog Chem Fats Other Lipids 1968 9 279–348.Google Scholar
Karsenty, GThe genetic transformation of bone biology. Genes Dev 1999 13 3037–3051.CrossRefGoogle ScholarPubMed
Korotkova, M, Gabrielsson, B, Hanson, LA & Strandvik, BMaternal essential fatty acid deficiency depresses serum leptin levels in suckling rat pups. J Lipid Res 2001 42 359–365.CrossRefGoogle ScholarPubMed
Korotkova, M, Ohlsson, C, Gabrielsson, B, Hanson, LA & Strandvik, BPerinatal essential fatty acid deficiency influences body weight and bone parameters in adult male rats. Biochim Biophys Acta 2005 1686 248–254.CrossRefGoogle ScholarPubMed
Korotkova, M, Ohlsson, C, Hanson, LA & Strandvik, BDietary n-6:n-3 fatty acid ratio in the perinatal period affects bone parameters in adult female rats. Br J Nutr 2004 92 643–648.CrossRefGoogle ScholarPubMed
Kuo, PT, Huang, NN & Bassett, DRThe fatty acid composition in serum chylomicrons and adipose tissue of children with cystic fibrosis of the pancreas. J Pediatr 1962 60 394–403.CrossRefGoogle ScholarPubMed
Lai, HC, Kosorok, MR, Laxova, A, Davis, LA, FitzSimmon, SC & Farrell, PMNutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening. Pediatrics 2000 105 53–61.CrossRefGoogle ScholarPubMed
Lannefors, L, Button, BM & McIlwaine, M, Physiotherapy in infants and young children with cystic fibrosis: current practice and future developments. J R Soc Med 2004 97 8–25.Google ScholarPubMed
Levistre, R, Lemnaouar, M, Rybkine, T, Béréziat, G & Masliah, JIncrease of bradykinin-stimulated arachidonic acid release in a DF508 cystic fibrosis epithelial cell line. Biochim Biophys Acta 1993 1181 233–239.CrossRefGoogle Scholar
Marks, SC Jr & Miller, SCProstaglandins and the skeleton: the legacy and challenges of two decades of research. Endocrine J 1993 1 337–344.Google Scholar
Miele, L, Cordella-Miele, E, Xing, M, Frizzell, R & Mukherjee, ABCystic fibrosis gene mutation (deltaF508) is associated with an intrinsic abnormality in Ca2-induced arachidonic acid release by epithelial cells. DNA Cell Biol 1997 16 749–759.CrossRefGoogle ScholarPubMed
Rogiers, V, Crokaert, R & Vis, HL, Altered phospholipid composition and changed fatty acid pattern of the various phospholipid fractions of red cell membranes of cystic fibrosis children with pancreatic insufficiency. Clin Chem Acta 1980 105 105–115.CrossRefGoogle ScholarPubMed
Salamoni, F, Roulet, M, Gudinchet, F, Pilet, M, Thiebaud, D & Burckhardt, PBone mineral content in cystic fibrosis patients: correlation with fat-free mass. Arch Dis Child 1996 74 314–318.CrossRefGoogle ScholarPubMed
Sermet-Gaudelus, I, Souberbielle, JC, Azhar, I, Ruiz, JC, Magnine, P, Colomb, V, Le Bihan, C, Foloi, D & Lenor, GInsulin-like growth factor 1 correlates with lean body mass in cystic fibrosis patients. Arch Dis Child 2003 88 956–961.CrossRefGoogle ScholarPubMed
Shimizu, T, Hansson, G & Strandvik, B, Defective inhibition by dexamethasone of leukotriene B-4- and C4 production by leukocytes in patients with cystic fibrosis. Prostagland Leukot Essent Fatty Acids 1994 51 407–410.CrossRefGoogle ScholarPubMed
Siguel, EN, Chee, KM, Gong, J & Schaefer, EJCriteria for essential fatty acid deficiency in plasma as assessed by capillary column gas-liquid chromatography. Clin Chem 1987 33 1869–1873.CrossRefGoogle ScholarPubMed
Sood, M, Hambleton, G, Super, M, Fraser, WD & Mughal, MZAdams, JEBone status in cystic fibrosis. Arch Dis Child 2001 84 516–520.CrossRefGoogle ScholarPubMed
Strandvik, BFatty acid metabolismin in cystic fibrosis. N Engl J Med 2004 5 605–607.CrossRefGoogle Scholar
Strandvik, B, Bjorck, E, Fallstrom, M, Gronowitz, E, Thountzouris, J, Lindblad, A, Markiewicz, D, Wahlstrom, J, Tsui, LC & Zielenski, JSpectrum of mutations in the CFTR gene of cystic fibrosis patients from southwestern Sweden: identification of 12 novel mutations. Genet Test 2001a 5 135–142.CrossRefGoogle ScholarPubMed
Strandvik, B, Gronowitz, E, Enlund, F, Martinsson, T & Wahlstrom, JEssential fatty acid deficiency in relation to genotype in patients with cystic fibrosis. J Pediatr 2001b 139 650–655.CrossRefGoogle ScholarPubMed
Strandvik, B, Svensson, E & Seyberth, HW, Prostanoid biosynthesis in patients with cystic fibrosis. Prostagland Leukot Essent Fatty Acids 1996 55 419–425.CrossRefGoogle ScholarPubMed
Underwood, BA, Denning, CR & Navab, M, Polyunsaturated fatty acids and tocopherol levels in patients with cystic fibrosis. Ann N Y Acad Sci 1972 203 237–247.CrossRefGoogle ScholarPubMed
Watkins, BA, Li, Y, Lippman, HE & Seifert, MFOmega-3 polyunsaturated fatty acids and skeletal health. Exp Biol Med 2001a 226 485–497.CrossRefGoogle ScholarPubMed
Watkins, BA, Li, Y & Seifert, MFNutraceutical fatty acids as biochemical and molecular modulators of skeletal biology. J Am Coll Nutr 2001b 20 410S–420S.CrossRefGoogle ScholarPubMed
Watkins, BA, Lippman, HE, Le Bouteiller, L, Li, Y & Seifert, MFBioactive fatty acids: role in bone biology and bone cell function. Progr Lipid Res 2001c 40 125–148.CrossRefGoogle ScholarPubMed